- pause slideshow
MHRA 'assessing reports' of respiratory illness outbreak linked to e-cigarettes in the United States
The Medicines and Healthcare products Regulatory Agency is reviewing information about a respiratory illness that has been linked to e-cigarette use in the United States.
The government risks making drugs shortages worse with its generics reimbursement reforms, unless the proposals are rolled out gradually, the Pharmaceutical Services Negotiating Committee has said.
Point-of-care C-reactive protein testing reduces antibiotic use in people with acute COPD exacerbations, a study published in The New England Journal of Medicine has shown.
Researchers have identified a plausible drug–drug interaction between laxatives and non-potassium-sparing diuretics.
Rimegepant, a medicine belonging to a new class of migraine treatments, relieves pain and other symptoms in patients with moderate or severe migraine pain, research published in The New England Journal of Medicine has shown.
Switching inhalers can boost adherenceSubscription
Inhaler switching in asthma and COPD is not associated with negative impacts on patients’ health, study results published in Thorax have shown.
National Institute for Health and Care Excellence guidelines from 2005 may have inadvertently led to increased antidepressant prescribing in children aged under 18 years.
Patients who take tramadol and methadone are at a higher risk of developing hypoglycaemia compared to those who take other opioids, a study has found.
Binning the sharps: the quest for oral insulinSubscription
The pharmaceutical industry has been trying to develop oral formulations of insulin since the 1920s without success, but, over the past few years, several new oral delivery systems have shown promise in clinical trials.
A summary of the main points of the new contract that community pharmacists in England need to know about before October 2019.
Case-based learning: sore throatSubscription
Marking the first World Patient Safety DaySubscription